Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Confirmatory Study of Laronidase in Japanese MPS I Patients
NCT00258011Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2005
- Primary completion
- Oct 2006
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of laronidase in mucopolysaccharidosis type I, sponsored by Sanofi. Started Dec 2005; status: completed.
02
Drugs
laronidase
03
Conditions
mucopolysaccharidosis type I
Beyond the preview
Go deeper on NCT00258011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00258011.